Sex: F
Vaccine: COVID19
Symptoms: Malaise, Peripheral swelling, Thrombosis, Varicose vein
Clinical narrative: pulmonary blood clots, diagnosed with a blood clot in their right leg; not feeling all that great; vein on their right leg above their knee was hard and purple; a massive swelling on their right leg; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (pulmonary blood clots, diagnosed with a blood clot in their right leg) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Patient had a medical history of DBT 20 years ago.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (pulmonary blood clots, diagnosed with a blood clot in their right leg) (seriousness criterion medically significant), MALAISE (not feeling all that great), VARICOSE VEIN (vein on their right leg above their knee was hard and purple) and PERIPHERAL SWELLING (a massive swelling on their right leg). At the time of the report, THROMBOSIS (pulmonary blood clots, diagnosed with a blood clot in their right leg), MALAISE (not feeling all that great), VARICOSE VEIN (vein on their right leg above their knee was hard and purple) and PERIPHERAL SWELLING (a massive swelling on their right leg) outcome was unknown.            Concomitant medications were not provided.    Patient's vein specialist prescribed to take daily shots of blood thinners for 6 weeks.  Company comment- This case concerns a female SUBJECT, unknown years-old, female, with a history of diabetes without treatment, who experienced the unexpected events of THROMBOSIS (pulmonary blood clots, diagnosed with a blood clot in their right leg) (seriousness criterion medically significant), MALAISE (not feeling all that great), VARICOSE VEIN (vein on their right leg above their knee was hard and purple) and PERIPHERAL SWELLING (a massive swelling on their right leg.  The event occurred approximately six months after SECOND DOSE, the most recent dose of [Spikevax].   The rechallenge was unknown. The benefit-risk relationship of the vaccine is not affected by this report.; Sender's Comments: This case concerns a female SUBJECT, unknown years-old, female, with a history of diabetes without treatment, who experienced the unexpected events of THROMBOSIS (pulmonary blood clots, diagnosed with a blood clot in their right leg) (seriousness criterion medically significant), MALAISE (not feeling all that great), VARICOSE VEIN (vein on their right leg above their knee was hard and purple) and PERIPHERAL SWELLING (a massive swelling on their right leg.  The event occurred approximately six months after SECOND DOSE, the most recent dose of [Spikevax].   The rechallenge was unknown. The benefit-risk relationship of the vaccine is not affected by this report. -MODERNATX, INC.-MOD-2021-317542: -MODERNATX, INC.-MOD-2021-317609:Same reporter and Patient but different event